Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
Aida uses machine learning and gene expression of individual tumors to help clinicians to prescribe the best drugs for each cancer patient.
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
Upstream Foods is developing a novel fat ingredient to uplevel seafood alternatives
Myco4Food is a biotechnology research company developing protein alternative novel foods from waste products.
Heka VR is a virtual reality platform developing a novel therapy to aid people suffering from auditory hallucinations.
Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.
Sevenless Therapeutics focus on manufacturing of pharmaceuticals.
Orbit Health focuses on developing an artificial intelligence solution that assists parkinson's disease patients.
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.
Paragit Solutions develops systems for improving care and diagnosis of movement disorders.
Probmet is a precision oncology therapeutics company developing treatments for cancer.
Ampa Medical provides healthcare services for people living with an ostomy.
Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.
Pephexia Therapeutics is a biotechnology company working with the discovery.
DIASENSE is creating a Quantum Diamond Magnetic Microscope that will be able to detect magnetic fields at high rates.
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat antimicrobial resistance.
Microminer is focused on developing innovative and sustainable technologies for extracting and recycling critical metals,
DARERL offers virtual human models for device development, providing digital anatomy based on real human bodies.
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Cambiotics mission is to reducing the widespread presence of chemicals in the body whc are spread through various everyday products.
EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries.
HHC Medical is a health tech company developing targeted non-invasive drug delivery devices.
BioInnovation Institute has invested in 157 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Medical, Biotechnology, Health Care, Medical Device, Therapeutics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Synklino received $32.0M in a Series A round. BioInnovation Institute's total known invested capital is $402.9M.
BioInnovation Institute's average investment size is $3.6M across its portfolio of 157 companies.
Recent BioInnovation Institute portfolio additions include MELLO, Aida Oncology, Amplify Therapeutics, Kesmalea Therapeutics, Upstream Foods. These companies were founded in 2020 or later.